Find investors
← Back to all investors
Aleks Sobot
ResearchedAngel Investors

Aleks Sobot

Associate

Angel InvestorsSeed Round
Pitch Aleks

Get their honest, personalized take on your startup.

Sign in to pitch Aleks

At a glance

Full Name
Aleksandar (Aleks) Sobot, CFA
Title
Founder & Principal, Aevi Capital; CEO, ATS Scientific Inc. (former Associate, Signal Hill Equity Partners)
Firm
Aevi Capital
Firm Type
Private capital / succession-focused buyout investor (not a traditional angel or seed fund)
Investment Stage
Established, cash-flowing private businesses (control/majority buyouts and succession deals) — *note: the source stub's "Seed Round / Angel Investor" classification does not match his actual buyout/succession focus*
Check Size
Not publicly disclosed
Target Company Profile
Businesses with $1M+ in EBITDA (smaller considered in select industries), margins over 10%, high recurring/contracted revenue, in stable or growing, low-concentration industries; typically acquiring majority stakes
Sector Focus
Sector-agnostic within stable, growing industries (his own operating investment, ATS Scientific, is in analytical instrumentation / laboratory equipment)
Geographic Focus
Canada (Toronto-based), primarily domestic mid-market
Location
Toronto, Ontario, Canada

Background

Aleks Sobot is a Toronto-based investor and operator who currently serves as Founder & Principal of Aevi Capital and as CEO of ATS Scientific Inc. He is a CFA Charterholder and graduated as an Ivey Scholar from the Richard Ivey School of Business (Western University) — a distinction awarded to top students in the program.

Before founding his own firm, Sobot built a career across private equity, hedge funds, and restructuring advisory. He was an Associate on the investment team of Signal Hill Equity Partners, a leading Canadian middle-market private equity firm, where he sourced, analyzed, and conducted due diligence on new acquisition opportunities, building leveraged-buyout analyses and financial models for potential platform investments. His earlier experience includes an investment/analyst role at one of Canada's largest hedge funds (Anson Funds) and a role at a global advisory firm (Alvarez & Marsal) focused on corporate turnarounds and distressed M&A.

In 2020 he founded Aevi Capital to combine his entrepreneurial mindset with his private-capital background, positioning the firm as a "growth-minded investment firm that provides a flexible, tailor-made succession solution... focused on the wants and needs of the entrepreneur." In October 2021, Aevi Capital — alongside Sage Capital Partners — acquired ATS Scientific Inc., a Burlington, Ontario supplier of analytical instrumentation and laboratory equipment with a 30+ year history. Sobot stepped in as CEO of ATS Scientific following the acquisition and has led its growth since, including add-on M&A.

Investment Thesis & Focus

  • Succession-driven buyouts, not venture/seed. Aevi targets founders and owners seeking a transition, offering a "flexible, tailor-made succession solution" rather than a one-size-fits-all exit.
  • Quality-of-earnings screen: businesses with $1M+ EBITDA (smaller in select cases), margins over 10%, and a high proportion of recurring and/or contracted revenue.
  • Industry preference: "stable or growing industries with a low level of concentration" and companies that "exhibit high growth potential in a large, stable industry."
  • Control-oriented: Aevi states it "invest[s] in majority stakes" and acts as a "hands-on partner" — Sobot's own move into the ATS Scientific CEO seat exemplifies this operator-investor model.
  • What makes him say yes: durable, defensible cash flows plus a genuine ownership-transition need where an entrepreneurial, operationally engaged buyer adds value.

Notable Investments

  • ATS Scientific Inc. — Analytical instrumentation and laboratory equipment supplier (Burlington, ON). Acquired October 2021 by Aevi Capital with Sage Capital Partners; Sobot became CEO. His flagship platform investment.
  • Folio Instruments Inc. — Add-on acquisition by ATS Scientific (announced ~2024), expanding its instrumentation product and service footprint.
  • Signal Hill Equity platform deals — As an Associate he supported diligence and modeling on the firm's Canadian middle-market platform investments; specific deals are not individually attributed to him publicly.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.